The field of diabetes treatment has seen a surge in innovation with the emergence of novel GLP-1 receptor agonists. Among these, retatrutide and trizepatide stand out as potential game-changers. These of medications https://lillivrnk314229.smblogsites.com/39099188/novel-glp-1-receptor-agonists-retatrutide-and-trizepatide